2013Chinese Heart JournalRequires access

Effect of combination of ezetimibe and atorvastatin on serum lipid in elderly patients with coronary artery disease

Yang Don

Open publisher page 0 citations

Abstract

AIM:To observe the effect of combination of ezetimibe and atorvastatin on the serum lipid of elderly patients with coronary heart disease.METHODS:One hundred and seventy-six elderly patients with coronary artery disease whose serum lipid level did not meet normal criteria after taking atorvastatin20 mg/d were assigned randomly to two groups.Patients in high-dose atorvastatin group were treated with atorvastatin 40 mg/d and patients in combination group were treated with ezetimibe 10 mg/d and low-dose atorvastatin 20 mg/d.The changes of serum lipid and side effects were compared between the two groups.RESULTS:Total cholesterol(TC) and low density lipoprotein-cholesterol(LDL-C) decreased significantly in both groups after the 12-week therapy(P 0.05).Compared with those in high-dose atorvastatin group,serum TC and LDL-C decreased markedly(P 0.05) and serum lipid control rate was much higher in combination group.However,the rate of hepatic damage in combination group was much lower than that in high-dose atorvastatin group.CONCLUSION;Compared with high-dose atorvastatin,combination of ezetimibe and low-dose atorvastatin,safe and well-tolerated,can more significantly decrease TC and LDL-C and improve serum lipid control rate.

About this research paper

What this paper is about

AIM:To observe the effect of combination of ezetimibe and atorvastatin on the serum lipid of elderly patients with coronary heart disease.METHODS:One hundred and seventy-six elderly patients with coronary artery disease whose serum lipid level did not meet normal criteria after taking atorvastatin20 mg/d were assigned randomly to two groups.Patients in high-dose atorvastatin group were treated with atorvastatin 40 mg/d and patients in combination group were treated with ezetimibe 10 mg/d and low-dose atorvastatin 20 mg/d.The changes of serum lipid and side effects were compared between the two groups.RESULTS:Total cholesterol(TC) and low density lipoprotein-cholesterol(LDL-C) decreased significantly in both groups after the 12-week therapy(P 0.05).Compared with those in high-dose atorvastatin group,serum TC and LDL-C decreased markedly(P 0.05) and serum lipid control rate was much higher in combination group.However,the rate of hepatic damage in combination group was much lower than that in high-dose atorvastatin group.CONCLUSION;Compared with high-dose atorvastatin,combination of ezetimibe and low-dose atorvastatin,safe and well-tolerated,can more significantly decrease TC and LDL-C and improve serum lipid control rate.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To observe the effect of combination of ezetimibe and atorvastatin on the serum lipid of elderly patients with coronary heart disease.METHODS:One hundred and seventy-six elderly patients with coronary artery disease whose serum lipid level did not meet normal criteria after taking atorvastatin20 mg/d were assigned randomly to two groups.Patients in high-dose atorvastatin group were treated with atorvastatin 40 mg/d and patients in combination group were treated with ezetimibe 10 mg/d and low-dose atorvastatin 20 mg/d.The changes of serum lipid and side effects were compared between the two groups.RESULTS:Total cholesterol(TC) and low density lipoprotein-cholesterol(LDL-C) decreased significantly in both groups after the 12-week therapy(P 0.05).Compared with those in high-dose atorvastatin group,serum TC and LDL-C decreased markedly(P 0.05) and serum lipid control rate was much higher in combination group.However,the rate of hepatic damage in combination group was much lower than that in high-dose atorvastatin group.CONCLUSION;Compared with high-dose atorvastatin,combination of ezetimibe and low-dose atorvastatin,safe and well-tolerated,can more significantly decrease TC and LDL-C and improve serum lipid control rate.

Key concepts: Atorvastatin, Ezetimibe, Medicine, Coronary artery disease, Internal medicine, Gastroenterology, Coronary heart disease, Lipid profile

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of combination of ezetimibe and atorvastatin on serum lipid in elderly patients with coronary artery disease — Research Paper | ScholarLens